Document And Entity Information
Document And Entity Information | Jun. 19, 2024 |
Cover [Abstract] | |
Document Type | 8-K |
Amendment Flag | false |
Document Period End Date | Jun. 19, 2024 |
Entity Registrant Name | Iterum Therapeutics plc |
Entity Central Index Key | 0001659323 |
Entity Emerging Growth Company | false |
Entity File Number | 001-38503 |
Entity Incorporation, State or Country Code | L2 |
Entity Tax Identification Number | 00-0000000 |
Entity Address, Address Line One | Fitzwilliam Court |
Entity Address, Address Line Two | 1st Floor |
Entity Address, Address Line Three | Leeson Close |
Entity Address, City or Town | Dublin 2 |
Entity Address, Country | IE |
Entity Address, Postal Zip Code | Not applicable |
City Area Code | +353 |
Local Phone Number | 1 6694820 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | Ordinary Shares, par value $0.01 per share |
Trading Symbol | ITRM |
Security Exchange Name | NASDAQ |